Total-Backed Amyris Gets $11 Million for Research on Farnesene
The debt taken on by Emeryville, California-based Amyris came from convertible notes, Joel Velasco, a company spokesman, said today in an e-mail.
Total, Amyris’s largest shareholder, owned almost 21 percent of Amyris as of May 29, according to data compiled by Bloomberg.
Amyris deploys genetically modified microorganisms to convert plant sugars into fragrance oils or farnesene, a hydrocarbon used to make specialty chemicals or fuels.
To contact the reporter on this story: Justin Doom in New York at email@example.com
To contact the editors responsible for this story: Reed Landberg at firstname.lastname@example.org Robin Saponar